BioGaia

Major Shareholding Notification • Mar 26, 2014

Press Release 26 March 2014

Sale of shares in BioGaia AB

Annwall & Rothschild Investments AB (A & R AB) has due to private financial reasons sold 500,000 B-shares in BioGaia AB to a few long term investors. After the sale A & R AB owns 8.7 % of the capital and 34.1 % of the votes. A & R AB has no intention to sell additional shares in BioGaia in the foreseeable future.

For additional information please contact Peter Rothschild, President, telephone: +46 8 555 293 00

Latest press releases from BioGaia

2014-03-17	New study shows that it is possible to prevent common infections in children
2014-03-12	BioGaia enters new, extended agreement with Nestlé
2014-02-17	BioGaia receives the first instalment of additional payment from Nestlé

BioGaia has published this information in accordance with the Swedish Securities Market Act. The information was issued for publication on 26 March 2014, 08:45 am CET.

BioGaia is a healthcare company that develops, markets and sells probiotic products with documented health benefits. The products are primarily based on the lactic acid bacterium Lactobacillus reuteri which has probiotic, health-enhancing effects. The class B share of the Parent Company BioGaia AB is quoted on the Mid Cap list of the NASDAQ OMX Nordic Exchange Stockholm. www.biogaia.com